Harbour BioMed has entered a strategic partnership with Otsuka focusing on the development of HBM7020 for treating autoimmune ...

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Dedicated datasets highlight how social determinants of health can be used to improve overall standards of care.

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...